Apr 132018
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, today announced the appointment on April 11, 2018 of Rolf K.=> Read Full post

Paratek Pharmaceuticals appointed Rolf Hoffman to its Board of Directors

From:: Paratek Pharmaceuticals appointed Rolf Hoffman to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: